Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study
SGLT2抑制剂和GLP-1受体激动剂联合用药对2型糖尿病患者eGFR下降的影响:RECAP研究的事后分析
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1358573
Muta, Yoshimi; Kobayashi, Kazuo; Toyoda, Masao; Tone, Atsuhito; Suzuki, Daisuke; Tsuriya, Daisuke; Machimura, Hideo; Shimura, Hidetoshi; Takeda, Hiroshi; Yokomizo, Hisashi; Takeshita, Kei; Chin, Keiichi; Kanasaki, Keizo; Tamura, Kouichi; Miyauchi, Masaaki; Saburi, Masuo; Morita, Miwa; Yomota, Miwako; Kimura, Moritsugu; Hatori, Nobuo; Nakajima, Shinichi; Ito, Shun; Tsukamoto, Shunichiro; Murata, Takashi; Matsushita, Takaya; Furuki, Takayuki; Hashimoto, Takuya; Umezono, Tomoya; Takashi, Yuichi; Kawanami, Daiji